Literature DB >> 16937403

The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells.

Philippe Chatellard1, Renata Pankiewicz, Evelyne Meier, Laurence Durrer, Christophe Sauvage, Markus O Imhof.   

Abstract

Protein expression in mammalian cells is key for the production and manufacturing of bio-therapeutics with human-like properties and activities. As a molecular basis for reaching high protein expression levels, efficient promoter/enhancer systems are a prerequisite. Here we identify a novel enhancer from the mouse cytomegalovirus (CMV) immediate early 2 (IE2) region as a strong expression-promoting element. We further demonstrate its activity in bi-directional promoter architecture and apply it to generate production clones for IL-18BP, a protein with therapeutic indications in autoimmune diseases. These data show that the IE region from mouse CMV, and the IE2 enhancer/promoter in particular, have a broad potential for application in novel gene expression systems for research, development, and manufacturing of protein drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16937403     DOI: 10.1002/bit.21172

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.

Authors:  Jürgen Podlech; Rares Pintea; Kai A Kropp; Annette Fink; Niels A W Lemmermann; Katja C Erlach; Elena Isern; Ana Angulo; Peter Ghazal; Matthias J Reddehase
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

Review 2.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

3.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 4.  Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.

Authors:  Christof K Seckert; Marion Griessl; Julia K Büttner; Sabine Scheller; Christian O Simon; Kai A Kropp; Angélique Renzaho; Birgit Kühnapfel; Natascha K A Grzimek; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-19       Impact factor: 3.402

5.  Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.

Authors:  Kai A Kropp; Kevin A Robertson; Garwin Sing; Sara Rodriguez-Martin; Mathieu Blanc; Paul Lacaze; Muhamad F B Noor Hassim; Mizanur R Khondoker; Andreas Busche; Paul Dickinson; Thorsten Forster; Birgit Strobl; Mathias Mueller; Stipan Jonjic; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.

Authors:  Christian O Simon; Birgit Kühnapfel; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

7.  Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues.

Authors:  Vanessa Wilhelmi; Christian O Simon; Jürgen Podlech; Verena Böhm; Torsten Däubner; Simone Emde; Dennis Strand; Angélique Renzaho; Niels A W Lemmermann; Christof K Seckert; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

8.  Efficient expression from one CMV enhancer controlling two core promoters.

Authors:  Christina Rottbøll Andersen; Lars Søegaard Nielsen; Alexandra Baer; Anne Bondgaard Tolstrup; Dietmar Weilguny
Journal:  Mol Biotechnol       Date:  2011-06       Impact factor: 2.860

Review 9.  Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

Authors:  Seleeke Flingai; Matias Czerwonko; Jonathan Goodman; Sagar B Kudchodkar; Kar Muthumani; David B Weiner
Journal:  Front Immunol       Date:  2013-11-04       Impact factor: 7.561

10.  Hypoxic response elements and Tet-On advanced double-controlled systems regulate hVEGF 165 and angiopoietin-1 gene expression in vitro.

Authors:  Hao Zhang; Hongyan Dong; Bo Jiang; Zheng Wang; Rui Chen; Zhifeng Zhang; Zhongming Zhang
Journal:  J Biomed Res       Date:  2011-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.